© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
CURE Media Group, the nation's leading digital and print media enterprise focused on patients with cancer, has added the St. Baldrick's Foundation to its Advocacy Spotlight Partnership program to provide readers and website visitors with timely content from this volunteer-powered charity dedicated to raising money for lifesaving childhood cancer research.
PLAINSBORO, N.J. — (March 17, 2016) — CURE Media Group, the nation’s leading digital and print media enterprise focused on patients with cancer, has added the St. Baldrick’s Foundation to its Advocacy Spotlight Partnership program to provide readers and website visitors with timely content from this volunteer-powered charity dedicated to raising money for lifesaving childhood cancer research.
As partners in the program, both organizations will supply timely information about fundraising, grants, activities, trends, issues, educational and fundraising opportunities and programs related to the fight against childhood cancers. The information will be used as content across CURE Media Group communications and content services.
“The St. Baldrick's Foundation funds more in childhood cancer research grants than any other organization except for the U.S. government,” says Mike Hennessy Jr., president of CURE Media Group. “In addition to funding collaborative research so that research, currently underway, by the best and brightest investigators can be shared between institutions, and even across continents, all of St. Baldrick’s initiatives have a common goal of giving children with cancer the best chance for a cure. Our collective target audiences will benefit greatly from information stemming from this remarkable organization.”
As the largest private funder of childhood cancer research grants, the St. Baldrick’s Foundation believes that kids are special and deserve to be treated that way. The Foundation works closely with leading pediatric oncologists to determine the most promising research to fund, and to create funding priorities that make the greatest impact for children with cancer. Since 2005, St. Baldrick’s has awarded more than $178 million to support the most promising research so kids with cancer can get back to what’s important: just being kids.
“St. Baldrick’s is excited to join forces with an organization so closely aligned with our commitment to educating the world about all childhood cancers,” says St. Baldrick’s CEO Kathleen Ruddy. “Worldwide, 175,000 children are diagnosed with cancer each year, and in the U.S. alone, more children die of childhood cancer than any other disease. Through our work with CURE Media Group, we hope to educate, inspire and update those who have and have not been affected by childhood cancer by providing content on the mission of St. Baldrick’s, work being done though our advocacy network and the latest new discoveries in childhood cancer research.”
About CURE Media Group
Combining science and humanity to make cancer understandable, CURE Media Group’s flagship product, CURE® magazine, is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers, CURE is the largest U.S. consumer publication focused entirely on cancer, with broad distribution to patients with cancer, cancer centers and advocacy groups. CURE Media Group’s offerings also include its online resource, curetoday.com, live meetings, a resource guide for the newly diagnosed, and the Extraordinary Healer™ oncology nursing award. It also offers CURE Connections, a video platform designed specifically for patients with cancer that features information, stories, advice about the cancer journey and subscription options to receive updates. Cure Media Group is part of Michael J. Hennessy Associates Inc., a full-service health care communications company offering education, research, medical media and the acclaimed OncLive platform of resources for the practicing oncologist.
# # #
Michael J. LaCosta
CURE Media Group
St. Baldrick’s Foundation
626-792-8247 ext. 250